Christelle Rossey
About Christelle Rossey
Christelle Rossey is the Associate Director of Medical Affairs, Immuno-Oncology, Melanoma at Bristol Myers Squibb in Rueil-Malmaison, Île-de-France, France. She has over 15 years of experience in the pharmaceutical industry, focusing on oncology, cardiology, and immunology.
Company
Christelle Rossey currently works at Bristol Myers Squibb as the Associate Director of Medical Affairs, Immuno-Oncology, Melanoma. Based in Rueil-Malmaison, Île-de-France, France, she plays a crucial role in the company’s medical strategies and operations within the field of melanoma treatment.
Title
Christelle Rossey holds the title of Associate Director Medical Affairs, Immuno-Oncology, Melanoma. She is involved in overseeing medical affairs strategies and ensuring clinical insights and pharmaceutical developments intersect effectively with patient needs and treatment protocols.
Education and Expertise
Christelle Rossey earned a Mastère in Management Médical from ESCP-EAP in 2002. Prior to this, she achieved a Docteur en pharmacie from Université Paris-Sud (Paris XI) in 2002. Her expertise spans over 15 years in the pharmaceutical industry, with a focus on oncology, cardiology, and immunology. She has extensive experience in product training and medical education.
Professional Background
Christelle Rossey has held numerous roles in significant pharmaceutical companies. At Bristol Myers Squibb, she transitioned from Medical Science Manager roles in both oncology and cardiology to becoming Strategy and Operational Medical Lead Oncology. Prior roles include serving as a Formateur Produits at Menarini and Schering-Plough Research Institute, where she worked across immunology, allergology, and cardiology. She also managed international markets as Chef de Produits Export, focusing on regions including Maghreb, Africa, and DOM-TOM.
Strategic Medical Affairs Leadership
Christelle Rossey brings a strong background in both medical science management and strategic operations within the oncology field. Throughout her career at Bristol Myers Squibb, she has steered medical strategies, particularly in immuno-oncology and melanoma, integrating clinical insights with the company's pharmaceutical advancements.